158 related articles for article (PubMed ID: 3110692)
21. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
Vanholder RC; Ringoir SM
Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890
[TBL] [Abstract][Full Text] [Related]
22. Cystatin C: a new marker of biocompatibility or a good marker for the redistribution of LMW proteins during hemodialysis?
Thysell H; Grubb A; Lindholm T; Ljunggren L; Mårtensson L
ASAIO Trans; 1988; 34(3):202-4. PubMed ID: 3058174
[TBL] [Abstract][Full Text] [Related]
23. Serum beta 2-microglobulin levels in patients chronically dialyzed with CA-210 versus CT-190 dialysis membranes.
DeFranco P; Farrell J; Gellens M; Bastani B
Am J Nephrol; 1998; 18(1):16-20. PubMed ID: 9481434
[TBL] [Abstract][Full Text] [Related]
24. Effects of a polyelectrolyte additive on the selective dialysis membrane permeability for low-molecular-weight proteins.
Krieter DH; Morgenroth A; Barasinski A; Lemke HD; Schuster O; von Harten B; Wanner C
Nephrol Dial Transplant; 2007 Feb; 22(2):491-9. PubMed ID: 17050637
[TBL] [Abstract][Full Text] [Related]
25. Acute effect of haemodialysis on arterial stiffness: membrane bioincompatibility?
Mourad A; Carney S; Gillies A; Jones B; Nanra R; Trevillian P
Nephrol Dial Transplant; 2004 Nov; 19(11):2797-802. PubMed ID: 15340092
[TBL] [Abstract][Full Text] [Related]
26. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
[TBL] [Abstract][Full Text] [Related]
27. Serum low-molecular-weight proteins in haemodialysis patients: effect of residual renal function.
Brown PH; Kalra PA; Turney JH; Cooper EH
Nephrol Dial Transplant; 1988; 3(2):169-73. PubMed ID: 2459634
[TBL] [Abstract][Full Text] [Related]
28. Beta 2-microglobulin kinetics during haemofiltration.
Floege J; Wilks M; Shaldon S; Koch KM; Smeby LC
Nephrol Dial Transplant; 1988; 3(6):784-9. PubMed ID: 3147420
[TBL] [Abstract][Full Text] [Related]
29. [Cystatin C, beta2-microglobulin and C-reactive protein in hemodiafiltration and on-line endogenous liquid reinfusion and in low flux polysulphone bicarbonate conventional hemodialysis].
Cristofano C; Vernaglione L; Perniola MA; Lo Barco C; Muscogiuri P; Chimienti S
G Ital Nefrol; 2004; 21 Suppl 30():S197-200. PubMed ID: 15750984
[TBL] [Abstract][Full Text] [Related]
30. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
Pellicano R; Polkinghorne KR; Kerr PG
Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
[TBL] [Abstract][Full Text] [Related]
31. Effect of dialyzer membranes on beta-2 microglobulin production in Thai hemodialysis patients.
Domrongkitchaiporn S; Chuncharunee S; Archararit N; Atamasirikul K; Vanichakarn S
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S138-43. PubMed ID: 9347661
[TBL] [Abstract][Full Text] [Related]
32. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
Szepietowski T; Krajewska M
Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601
[TBL] [Abstract][Full Text] [Related]
33. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
Grooteman MP; Nubé MJ; van Limbeek J; van Houte AJ; Daha MR; van Geelen JA
ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
[TBL] [Abstract][Full Text] [Related]
34. Clinical comparison of high-flux cellulose acetate and synthetic membranes.
Hoenich NA; Woffindin C; Matthews JN; Goldfinch ME; Turnbull J
Nephrol Dial Transplant; 1994; 9(1):60-6. PubMed ID: 8177478
[TBL] [Abstract][Full Text] [Related]
35. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration.
Fry AC; Singh DK; Chandna SM; Farrington K
Blood Purif; 2007; 25(3):295-302. PubMed ID: 17622712
[TBL] [Abstract][Full Text] [Related]
36. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
Mrowka C; Heintz B; Sieberth HG
Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
[TBL] [Abstract][Full Text] [Related]
37. Statistical and parametric analysis of beta-2-microglobulin removal from uremic patients in high flux hemodialysis.
Lee CJ; Hsiong CH; Chang YL; Cheng CH; Lian JD
ASAIO J; 1994; 40(1):62-6. PubMed ID: 8186494
[TBL] [Abstract][Full Text] [Related]
38. Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients.
Wanner C; Bahner U; Mattern R; Lang D; Passlick-Deetjen J
Nephrol Dial Transplant; 2004 Oct; 19(10):2570-5. PubMed ID: 15280524
[TBL] [Abstract][Full Text] [Related]
39. A pilot, randomized, double-blind, cross-over study of high cut-off versus high-flux dialysis membranes.
Lee D; Haase M; Haase-Fielitz A; Paizis K; Goehl H; Bellomo R
Blood Purif; 2009; 28(4):365-72. PubMed ID: 19729908
[TBL] [Abstract][Full Text] [Related]
40. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
